127 results
8-K
EX-99.1
TRVN
Trevena Inc
1 Apr 24
Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update
6:00am
Exhibit 99.1
Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update
TRV045, novel S1P receptor modulator for chronic pain … with the optimized formulation. In addition, the live phase of the reproductive toxicology and sub-chronic toxicology studies have been completed, with final
8-K
EX-99.2
TRVN
Trevena Inc
1 Apr 24
Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update
6:00am
of opioids, even when used as recommended, especially in patients with chronic pulmonary disease, or in elderly, cachectic and debilitated patients
424B3
TRVN
Trevena Inc
23 Jan 24
Prospectus supplement
4:15pm
-opioid approach to managing chronic pain, as well as for treating epilepsy and seizure disorders. TRV045 has also demonstrated an anti-inflammatory … , and its mechanism of action suggests it may offer valuable benefits for two distinct areas of important unmet medical need: acute and chronic pain
8-K
EX-99.1
gntzt
8 Jan 24
Regulation FD Disclosure
7:01am
8-K
EX-99.2
n26jz
14 Nov 23
Trevena Reports Third Quarter 2023 Results and Provides Business Update
12:00am
8-K
EX-99.1
yhf27ijpu vrxfit9z
14 Nov 23
Trevena Reports Third Quarter 2023 Results and Provides Business Update
12:00am
8-K
EX-99.1
rgsm06asc8j4z8k1s34
2 Oct 23
Regulation FD Disclosure
7:05am
8-K
EX-99.2
nzm r7seldo
2 Oct 23
Regulation FD Disclosure
7:05am
8-K
EX-99.1
8h1disa
6 Sep 23
Regulation FD Disclosure
7:02am
8-K
EX-99.4
cfgmfut3 oormrw
6 Sep 23
Regulation FD Disclosure
7:02am
8-K
EX-99.3
hr8pwk2
6 Sep 23
Regulation FD Disclosure
7:02am
8-K
EX-99.2
1f3y4yr7r gpwgp
6 Sep 23
Regulation FD Disclosure
7:02am
8-K
EX-99.1
lztlu01yi8hmjfp3
14 Aug 23
Trevena Reports Second Quarter 2023 Results and Provides Business Update
7:05am
8-K
EX-99.1
9gwkceis
20 Jul 23
Trevena, Inc. Appoints Mark Corrigan, M.D. to Board of Directors
7:05am
8-K
EX-99.1
4udzwa7p
26 Jun 23
Trevena Announces New Topline OLINVYK Data Highlighting
7:05am
8-K
EX-99.1
flsdmqs mzj2psjlqq
30 May 23
Trevena Regains Compliance with Nasdaq Listing and Reaffirms Expected Near-Term Milestones
7:05am